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OBJECTIVE—Circulating angiogenic progenitor cells (APCs)
participate in endothelial repair after arterial injury. Type 2
diabetes is associated with fewer circulating APCs, APC dys-
function, and impaired endothelial repair. We set out to de-
termine whether insulin resistance adversely affects APCs and
endothelial regeneration.
RESEARCH DESIGN AND METHODS—We quantiﬁed APCs
and assessed APC mobilization and function in mice hemizygous
for knockout of the insulin receptor (IRKO) and wild-type (WT)
littermate controls. Endothelial regeneration after femoral artery
wire injury was also quantiﬁed after APC transfusion.
RESULTS—IRKO mice, although glucose tolerant, had fewer
circulating Sca-1+/Flk-1+ APCs than WT mice. Culture of mono-
nuclear cells demonstrated that IRKO mice had fewer APCs in
peripheral blood, but not in bone marrow or spleen, suggestive
of a mobilization defect. Defective vascular endothelial growth
factor–stimulated APC mobilization was conﬁrmed in IRKO mice,
consistent with reduced endothelial nitric oxide synthase (eNOS)
expression in bone marrow and impaired vascular eNOS activity.
Paracrine angiogenic activity of APCs from IRKO mice was im-
paired compared with those from WT animals. Endothelial re-
generation of the femoral artery after denuding wire injury was
delayed in IRKO mice compared with WT. Transfusion of mono-
nuclear cells from WT mice normalized the impaired endothelial
regeneration in IRKO mice. Transfusion of c-kit+ bone marrow
cells from WT mice also restored endothelial regeneration in
IRKO mice. However, transfusion of c-kit+ cells from IRKO mice
was less effective at improving endothelial repair.
CONCLUSIONS—Insulin resistance impairs APC function and
delays endothelial regeneration after arterial injury. These ﬁnd-
ings support the hypothesis that insulin resistance per se is
sufﬁcient to jeopardize endogenous vascular repair. Defective
endothelial repair may be normalized by transfusion of APCs
from insulin-sensitive animals but not from insulin-resistant
animals. Diabetes 60:1295–1303, 2011
Insulin resistance, the metabolic abnormality under-pinning type 2 diabetes and obesity, is an importantrisk factor for the development of atheroscleroticcardiovascular disease (1). Type 2 diabetes is pre-
dicted to affect 300 million people worldwide by 2025 (2);
as a result, the cardiovascular complications of type 2
diabetes will represent a major burden on global health
care systems. Despite optimal medical therapy, patients
with impaired glucose tolerance or type 2 diabetes have
substantially worse outcomes after an acute myocardial
infarction than patients without these metabolic abnor-
malities (3–6).
Recent clinical trials in which intensive lowering of
blood glucose failed to improve cardiovascular outcomes
in patients with type 2 diabetes (7,8) highlighted the im-
portance of identifying novel targets or approaches to
prevent or retard the development of atherosclerosis in
insulin-resistant individuals. Several components of the
type 2 diabetes phenotype have been implicated in the
pathogenesis of type 2 diabetes-related cardiovascular
disease (9); among these, insulin resistance has emerged
as an independent risk factor for the development of ath-
erosclerosis (1). The mechanisms underlying this effect,
however, remain only partially understood (10), and car-
diovascular beneﬁts of treatments directly targeting insulin
resistance have proved to be disappointing (11,12)
It is now an accepted pathophysiologic paradigm that
cardiovascular risk factors damage the endothelium and that
endogenous repair mechanisms are instituted to repair this
damage (13). The classical mechanism thought to underpin
endothelial cell (EC) repair and replacement is that local ECs
divide to re-endothelialize vessels. Evidence now supports
a complementary role to resident ECs for circulating vascular
progenitor cells derived from bone marrow (BM), and pos-
sibly other tissues, in the maintenance of EC function (13).
Direct evidence that angiogenic progenitor cells (APCs)—
early outgrowth endothelial progenitor cells or circulating
angiogenic cells—may contribute to endothelial regeneration
has emerged from animal studies demonstrating that APCs
incorporate into neoendothelium after endothelium-denuding
injury (14), bypass graft surgery (15), and hyperlipidemia (16)
and reduce the development of neointima, endothelial dys-
function, and atherosclerosis (17,18). These early-outgrowth
APCs are likely to be of monocytic origin and enhance
vascular repair by secreting proangiogenic cytokines (19).
Conversely, a less abundant population of late outgrowth
“endothelial colony-forming cells” may differentiate and
proliferate to repopulate the endothelium (19).
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Individuals with type 2 diabetes and obesity, and insulin-
resistant men of South Asian origin, all have EC dysfunc-
tion characterized by a reduction in the bioavailability of
the antiatherosclerotic signaling radical nitric oxide (NO)
(20–22). In mice hemizygous for knockout of the insulin
receptor (IRKO), in which normoglycemia is maintained
by compensatory hyperinsulinemia, we have shown that a
modest decline in insulin signaling results in substantially
reduced endothelial NO bioavailability, independent of hy-
perglycemia (23). Humans with diabetes have fewer circu-
lating endothelial progenitors, which are associated with
multiple functional defects that impair their regenerative
capacity (24–31).
A recent study in genetically diabetic db/db mice dem-
onstrated that type 2 diabetes is associated with reduced
APC numbers, APC dysfunction, and delayed endothelial
regeneration after injury (14). However, the effect of insulin
resistance per se on APCs and endothelial regeneration after
arterial injury remains unexplored. We have shown that
insulin-resistant young South Asian men have fewer circu-
lating APCs and impaired APC mobilization in response to
physiologic stimuli than insulin-sensitive white European
men (21,32). Here we investigate the effects of insulin re-
sistance on APCs and endothelial regeneration in IRKO
mice, a nonobese, nondiabetic model in which insulin sig-
naling in insulin-sensitive tissues is reduced by 30% (33).
RESEARCH DESIGN AND METHODS
Animals. IRKO mice (34) were obtained from the Medical Research Council
Mammalian Genetics Unit (Harwell, Oxfordshire, U.K.). Animals were main-
tained as heterozygotes on a C57BL/6 J background in a conventional animal
facility with a 12-h light/dark cycle and received a standard laboratory diet.
Male IRKO mice (aged 8–12 weeks) were compared with age- and sex-
matched wild-type (WT) littermates. Genotyping was performed using PCR on
ear notch genomic DNA, with primers speciﬁc for the gene-targeting cassette,
as previously described (23). All procedures were approved by the Ethical
Review Committee at the University of Leeds and were done in accordance
with the Animals (Scientiﬁc Procedures) Act of 1986. Because of inherent
difﬁculties in culturing late outgrowth endothelial colony cells from the blood
of insulin-resistant mice (35), we restricted our investigation to “early out-
growth” APCs.
Metabolic assessment. Intraperitoneal glucose- and insulin-tolerance tests
were performed in conscious, fasted animals, as previously described (23). At
30-minute intervals after an intraperitoneal injection of glucose (1 mg/g body
wt) or insulin (0.75 units/kg; Actrapid, Novo Nordisk, Bagsvaerd, Denmark),
blood glucose was measured using a glucometer (Accu-Chek, Aviva, Roche,
Basel, Switzerland).
Fluorescence-activated cell sorter enumeration of APCs. Saphenous
vein blood samples (100 mL) were incubated with PharmLyse (BD Biosciences,
San Jose, CA) at room temperature. After centrifugation, mononuclear cells
(MNCs) were resuspended in ﬂuorescence-activated cell sorter (FACS) buffer
and incubated with FcR blocker (BD Biosciences) at 4°C. Appropriate vol-
umes of the following antibodies, or their respective isotype controls, were
then added for 10 minutes at 4°C: ﬂuorescein isothiocyanate (FITC) anti-
mouse Sca-1 and PE anti-mouse Flk-1 (BD Biosciences). APCs were enu-
merated using ﬂow cytometry (BD FACS Calibur) to quantify dual-stained
Sca-1/Flk-1 cells. Isotype control specimens were used to deﬁne the threshold
for antigen presence and to subtract nonspeciﬁc ﬂuorescence. The cytometer
was set to acquire 100,000 events within the lymphocyte gate, deﬁned by
typical light scatter properties.
To assess APC mobilization, mice received an intraperitoneal injection of
5 mg of vascular endothelial growth factor (VEGF) on four consecutive days,
as previously described (36). Sca-1/Flk-1 cells were quantiﬁed using FACS
analysis at baseline and at day 4 after treatment.
Western blot analysis of BM lysates. BM, which was isolated by ﬂushing
harvested femurs and tibias with ice-cold Dulbecco’s modiﬁed Eagle’s medium,
was resuspended by pipetting through a 70-mm cell strainer and centrifuged
brieﬂy. Erythrocytes were removed using Erythrocyte Lysis Buffer (Sigma-
Aldrich, St. Louis, MO). Protein was extracted in lysis buffer and quantiﬁed
using the protein BCA assay (Sigma-Aldrich). Then, 50 mg of protein were
separated by electrophoresis through 4–12% SDS-PAGE gels (Invitrogen Life
Technologies, Carlsbad, CA) and blotted onto polyvinylidene ﬂuoride mem-
branes. Blots were probed with 1:1000 eNOS, 1:1000 Ser1177phospho eNOS,
and 1:3000 actin antibodies (BD Bioscience), as previously described (37).
Human umbilical vein EC lysates were used as a positive control for all blots.
Aortic eNOS activity.We have previously demonstrated that IRKO mice have
reduced aortic NO production in organ bath studies and in studies assessing
serine phosphorylation of eNOS in response to systemic insulin (23). Here we
assessed the effect of insulin (100 nmol/L) on eNOS activity in aortas by
quantifying the conversion of [14C]L-arginine to [14C]L-citrulline, as previously
described (37).
Preparation of MNCs. Spleens were harvested and mechanically minced.
MNCs were isolated using density-gradient centrifugation (Histopaque-1083,
Sigma) and were then stained with Cell-Tracker CM-DiI (2 mg/mL; C7000,
Invitrogen). A total of 30 3 106 cells were resuspended in 200 mL of PBS for
intravenous injection.
In a subset of experiments, femurs and tibias were ﬂushedwith magnetic cell
sorting (MACS) buffer to collect BM. BM-derived cells were subjected to
magnetic bead separation to collect CD117+ (C-kit receptor) cells. In brief, BM-
derived cells were washed, resuspended, and magnetically labeled with CD117
microbeads (MACS Microbeads, Miltenyi Biotech GmbH, Bergisch Gladbach,
Germany). After incubation and additional washing, magnetic cell separation
was performed using a separation column placed in a magnetic ﬁeld of
a magnetic bead separator (MACS Separation Columns, Miltenyi). The at-
tached CD117+ cells were collected in buffer and were resuspended in 200 mL
of MACS buffer for intravenous injection.
APC isolation and culture.MNCs from 1mL of blood, obtained from the vena
cava under terminal anesthesia, were isolated by Histopaque-1083 (Sigma)
density gradient centrifugation. MNCs were seeded on ﬁbronectin 24-well
plates (BD Biosciences) at a density of 53 106 cells/well. Cells were cultured in
EC growth (EGM-2) medium supplemented with EGM-2 Bullet kit (Lonza,
Basel, Switzerland) in addition to 20% FCS.
Spleens obtained from mice under terminal anesthesia were mechanically
minced. MNCs were isolated by density gradient centrifugation, as described
above. After washing steps, cells were seeded on ﬁbronectin 24-well plates at
a seeding density of 8 3 106 cells/well and cultured as described above.
Femurs and tibias were ﬂushed three times in DMEM with a 26-gauge needle
to collect BM. MNCs were isolated by density gradient centrifugation as de-
scribed above. After washing steps, cells were seeded on ﬁbronectin 24-well
plates at a seeding density of 13 106 cells/well and cultured as described above.
APC characterization. After 4 days of incubation at 37°C in 5% CO2, non-
adherent cells were discarded by gentle washing with PBS and adherent
cells resuspended in medium. At day 7, attached cells from peripheral
blood, spleen, and BM were stained for the uptake of 1,1’-dioctadecy-3,3,39,39-
tetramethyllindocarbocyanine-labeled acetylated low-density lipoprotein (DiI-
Ac-LDL) (Molecular Probes, Invitrogen, Carlsbad, CA) and lectin from Ulex
europaeus FITC conjugate (Sigma). Cells were ﬁrst incubated with DiI-Ac-LDL
at 37°C for 3 h and later ﬁxed with 4% paraformaldehyde for 10 minutes. Cells
were washed and reacted with lectin for 1 h. After staining, cells were quan-
tiﬁed by examining 10 random high-power ﬁelds (HPF) and double-positive
cells were identiﬁed as APCs and counted, as previously reported (38).
APC function: adhesion and in vitro angiogenesis assay. To evaluate
adhesion, 50,000 APCs were resuspended in EGM-2 medium, plated onto ﬁ-
bronectin 24-well plates, and incubated for 1 h at 37°C. After washing three
times with PBS, attached cells were counted. Adhesion was evaluated as the
mean number of attached cells per HPF (3100). The potential for APCs to
stimulate angiogenesis by secreting paracrine factors was assessed, as pre-
viously described (39). Brieﬂy, conditioned media were obtained by replacing
the medium of day 4 APC cultures with serum-free EGM-2 supplemented with
1% FCS and culturing the cells for an additional 24 h. APCs were counted, and
conditioned media was diluted to correct for cell numbers. After 24 h, tube
formation by human umbilical vein endothelial cell (HUVEC) on matrigel-
coated 24-well plates (BD Bioscience), in the presence of conditioned media,
was measured by staining the viable cells with hematoxylin-eosin (Sigma).
HUVEC cultures were used at passage 3–5. The number of endothelial tubes
was quantiﬁed per HPF (3100) (39).
Vascular injury. Mice were anesthetized with isoﬂurane (2.5–5%) before
a small incision was made in the midthigh and extended. Having carefully
isolated the femoral artery, an arteriotomy was made using iris scissors
(World-Precision Instruments, Sarasota, FL), and a 0.014-inch-diameter an-
gioplasty guidewire with tapered tip (Hi-torque Cross-it XT, Abbott-Vascular,
Abbott, IL), was introduced. The guidewire was advanced 3 cm, and three
passages were performed per mouse, resulting in complete arterial de-
nudation. The guidewire was removed completely and the suture was tight-
ened rapidly. The vessel was then ligated, and the skin was closed with
a continuous suture. The contralateral artery underwent an identical sham
operation, without passage of the wire. Animals received postoperative anal-
gesia with buprenorphine (0.25 mg/kg s.c.).
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Splenectomy. Mice were anesthetized with isoﬂurane, and the spleen was
dissected through a lateral incision of the left abdomen. Vessels were carefully
ligated using 6-0 silk. After removal of the spleen, the abdomen was closed with
single sutures using 6-0 silk.
Transfusion regimen. After splenectomy and vascular injury, IRKO and WT
mice received an intravenous injection of 30 3 106 ﬂuorescently labeled
spleen-derived MNCs from WT donors, as previously described (17). In a
separate set of experiments, IRKO mice received an intravenous injection of
6 3 106 c-kit receptor-positive BM-derived cells from WT and IRKO donors on
2 consecutive days after splenectomy and vascular injury. Control animals
underwent splenectomy and vascular injury and received a corresponding
amount of normal saline without cells. Femoral arteries were examined at
5 days for Evans blue staining and for en face ﬂuorescence microscopy.
En face microscopy. Mice were anesthetized at 3, 5, 7, and 14 days after wire
injury, and 50 mL of 5% Evans blue dye was injected into the vena cava. The
mice were perfused/ﬁxed with formaldehyde before the femoral arteries (in-
jured and uninjured) were harvested. The vessels were opened longitudinally.
The areas stained and unstained in blue were measured in the injured area
5 mm from the proximal suture, and the percentage areas were calculated
using ImagePro Plus 6.0 software (Media Cybernetics, Bethesda, MD).
A subset of perfusion-ﬁxed femoral arteries were opened longitudinally for en
face ﬂuorescence microscopy at day 5 after transfusion, embedded in mounting
medium containing the nuclear stain DAPI (VECTASHIELD, Vector Laboratories,
Burlingame, CA), and directly assessed for DiI and DAPI ﬂuorescence using
a Zeiss ApoTome imager Z1microscope (Carl Zeiss, Oberkochen, Germany). The
images were assessed using Axiovision 4.8.1 software (Zeiss).
Aortic ring angiogenesis assay. Descending thoracic aortas were excised and
ﬂushedwith ice-cold PBS until free of blood. Surrounding ﬁbroadipose tissuewas
dissected free, and the aorta sectioned into 1-mm rings. Culture plates (24-well)
were coated with 200 mL/well of growth factor–reduced Matrigel (BD Bio-
science) and then allowed to polymerize for 30 minutes at 37°C. Rings were
embedded on the growth factor–reduced Matrigel and incubated with Endo-
thelial Cell Growth Medium MV2 (PromoCell, Heidelberg, Germany), which was
replaced daily. Quantitative analysis of endothelial sprouting was performed
using images from day 7. The greatest distance from the aortic ring body to the
end of the vascular sprouts was measured at three distinct points per ring and in
three different rings per treatment group, as previously described (40).
Statistics. Data are presented as arithmetic mean and SEM, unless stated
otherwise. Graphic analyses were performed using Prism 5 software (Graph-
Pad Software, San Diego, CA). Continuous data were compared using unpaired,
two-tailed t tests for difference in means. Time-dependent re-endothelialization
was compared using two-way ANOVA. Post hoc t tests were performed with
application of a Bonferroni correction. Statistical signiﬁcance was accepted at
P , 0.05.
RESULTS
Metabolic homeostasis in IRKO mice. Blood glucose
concentrations were similar in IRKO and WT mice in the
fasting state (5.9 6 0.3 vs. 5.8 6 0.6 mmol/L; P = 0.89) and
after a glucose challenge (10.9 6 0.6 vs. 9.7 6 0.5 mmol/L;
P = 0.21). Insulin sensitivity, assessed by the hypoglyce-
mic response to intraperitoneal insulin administration, was
similar in IRKO and WT mice, with a glucose concentration
30 minutes after insulin administration of 5.2 6 0.4 vs 5.4 6
0.4 mmol/L (P = 0.63).
Quantiﬁcation of APCs. Sca-1/Flk-1+ APCs in peripheral
blood were signiﬁcantly reduced in IRKO mice compared
with WT controls (P , 0.05; Fig. 1A). To investigate
whether the reduced abundance of APCs we observed in
IRKO mice was attributable to impaired APC mobilization
from the BM, mice were treated with VEGF (5 mg i.p.) on 4
consecutive days, and Sca-1/Flk-1+ cells were quantiﬁed
before and after treatment. IRKO mice demonstrated sig-
niﬁcantly impaired APC mobilization in response to VEGF
compared with WT (P , 0.05; Fig. 1B).
Phenotypic analysis of in vitro APC culture. As a sec-
ond method of APC quantiﬁcation, DiI-ac-LDL/lectin+
APCs were expanded from peripheral blood-, spleen-, and
BM-derived MNCs, resulting in the growth of early-out-
growth APCs. These exhibited typical spindle-shaped mor-
phology on day 4 of culture. On day 7, cultivated cells were
incubated with DiI-ac-LDL and lectin. Cells staining positive
for both lectin and DiI-ac-LDL were quantiﬁed in 10 ran-
domly selected HPFs (Fig. 2A).
Signiﬁcantly fewer APCs were cultured from blood of
IRKO mice compared with WT controls (Fig. 2B). In con-
trast, there were no signiﬁcant differences in the numbers
of spleen- or BM-derived APCs cultured from the two
groups of mice (Fig. 2B).
BM eNOS expression and aortic eNOS activity. Be-
cause APC mobilization is critically dependent on NO
bioactivity, we investigated eNOS expression in BM and
eNOS activity in the vasculature. eNOS and Ser1177phos-
pho eNOS expression was demonstrated in BM from WT
animals but was undetectable in BM from IRKO mice (Fig.
3A). In aorta, insulin-stimulated eNOS activity, as assessed
by conversion of [14C]L-arginine to [14C]L-citrulline, was
signiﬁcantly blunted in the IRKO mice compared with WT
controls (Fig. 3B).
APC function: adhesion and in vitro angiogenesis
assay. There was no difference between IRKO and WT
in adhesive capacity of APCs to ﬁbronectin, an extracel-
lular matrix component involved in the initial steps of
angiogenesis (Fig. 4A). To further evaluate the effect of
insulin resistance on APC function, an in vitro angiogen-
esis assay was performed with conditioned medium of
cultured APCs from IRKO and WT mice. As shown in Fig.
4B, we observed a signiﬁcant reduction in tube formation
FIG. 1. Enumeration of APCs in blood using ﬂow cytometry. A: Numbers of Sca-1/Flk-1+ cells at baseline (P< 0.05; n = 9 per group). B: Mobilization
of Sca-1/Flk-1+ cells in response to VEGF administration (P < 0.05; n = 5 mice per group). Data are presented as mean and SEM.
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when HUVECs were subjected to conditioned media of
APCs derived from IRKO mice compared with that from
APCs derived from WT (P , 0.05), indicating reduced
paracrine angiogenic capacity of the IRKO cells. Importantly,
the difference in paracrine function was not a reﬂection of
lower APC numbers in IRKO, because the conditioned me-
dium was diluted to normalize for APC number.
Endothelial regeneration. IRKO and WT mice were
subjected to femoral artery-denuding wire injury. Evans
blue staining of whole-mounted femoral arteries conﬁrmed
that the entire injured segment was denuded of endothe-
lium immediately after wire injury (not shown). Evans blue
staining at intervals after the experimental injury demon-
strated that endothelial regeneration was signiﬁcantly
delayed in IRKO animals compared with WT (Fig. 5).
APC transfusion. To examine the potential therapeutic
effect of systemic administration of APCs on endothelial
repair, we performed APC transfusion experiments. IRKO
and WT mice initially received an intravenous femoral vein
injection of 30 3 106 ﬂuorescently labeled spleen-derived
MNCs from WT mice after vascular injury. To enhance
homing of the transfused cells to the injury site, mice were
splenectomized before injury. Control animals underwent
splenectomy and vascular injury and received a corre-
sponding volume of 0.9% saline vehicle. En face ﬂuorescence
microscopy 5 days after femoral artery injury revealed that
homing of transfused DiI-labeled cells was restricted to
the injury site, with no detectable ﬂuorescent cells in
noninjured regions or in the contralateral vessel (Fig. 6A).
Nuclear staining with DAPI and overlay experiments con-
ﬁrmed the presence of transfused cells in the injured en-
dothelium (Fig. 6B).
To evaluate the effect of transfused spleen-derived la-
beled MNCs on re-endothelialization in transfused and
placebo-treated mice, the de-endothelialized areas were
determined by Evans blue staining in a whole-vessel pre-
paration 5 days after vascular injury. Consistent with our
earlier observations, vehicle-treated IRKO mice who un-
derwent splenectomy and vascular injury displayed im-
paired endothelial regeneration compared with WT controls
(25 6 5 vs. 60 6 4%; P , 0.005). Transfusion of WT
MNCs into IRKO mice led to a signiﬁcant increase in re-
endothelialization (57 6 4%) compared with vehicle
alone (25 6 5%; P , 0.002; Fig. 6C).
FIG. 2. Enumeration of APCs derived from blood, spleen, and BM by cell culture. A: Fluorescence microscopy revealing the spindle-shaped APCs
(phase contrast image), lectin-bound (green), DiI-ac-LDL uptake (red), and dual-stained APCs (yellow; magniﬁcation 3100). B: Numbers of pe-
ripheral blood-, spleen- and BM-derived cultured APCs from uninjured mice are expressed as the percentage of cells derived fromWTmice (P< 0.05;
n = 6 mice per group). Data are presented as mean and SEM. (A high-quality digital representation of this ﬁgure is available in the online issue.)
FIG. 3. Expression and activity of eNOS. A: eNOS and Ser-1177 phospho eNOS expression was conﬁrmed in BM of WT animals but was undetectable
in BM of IRKO mice (n = 3 mice per group). B: Insulin-stimulated eNOS activity was measured in aortic rings from IRKO and WT mice (n = 6 mice
per group). Data are presented as mean and SEM.
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To further explore the therapeutic effect of APCs, BM-
derived cells from WT and IRKO mice that were positive
for c-kit receptor (stem cell marker CD 117) were obtained
by magnetic bead separation. Transfusion of WT cells
positive for c-kit receptor into IRKO mice (6 3 106/day for
2 days) signiﬁcantly improved endothelial regeneration
compared with placebo-treated IRKO (62 6 2 vs. 25 6 5%;
P , 0.002). Transfusion of IRKO cells positive for c-kit
receptor into IRKO mice also improved endothelial re-
generation compared with the vehicle-treated IRKO mice
(45 6 4 vs. 25 6 5%; P , 0.02), although this treatment
was not as effective as treatment with WT cells positive for
c-kit receptor (62 6 2 vs. 45 6 4%; P , 0.02; Fig. 6C).
Aortic ring angiogenesis assay. This in vitro assay
closely simulates in vivo angiogenesis, not only because it
includes the surrounding non-ECs but also because the
ECs have not been preselected by ex vivo expansion (41).
There was no difference in the length of aortic microvessel
sprouting between aortic explants from WT and IRKO
mice, indicating no impairment in angiogenic potential of
native mature ECs in the vasculature of IRKO mice (Fig. 7A
and B).
DISCUSSION
This report provides a number of novel insights into the
effect of whole-body insulin resistance on endothelial re-
generative mechanisms:
 we show that IRKO mice have impaired endothelial re-
parative capacity after endothelium-denuding arterial
injury;
 consistent with our recent ﬁndings in insulin-resistant
humans, APC mobilization is blunted in IRKO mice;
 in vitro APC functionality is impaired in IRKO mice;
 transfusion of different APC subsets from WT mice
enhances endothelial regeneration in IRKO mice; and
 transfusion of IRKO APCs into IRKO mice improves en-
dothelial regeneration but not to the same extent as
transfusion of WT cells.
FIG. 4. APC functional assays. A: Adhesion capacity of APCs cultured from IRKO and WT mice expressed as number of cells adhering to ﬁbro-
nectin-coated plates (n = 4 mice per group). B: Endothelial tube formation in response to conditioned medium from WT and IRKO APCs (P < 0.05;
n = 4 mice per group). Data are presented as mean and SEM.
FIG. 5. Endothelial regeneration after wire injury of the femoral artery. A: Representative in situ Evans blue staining in an uninjured vessel and
vessels at 3, 5, and 14 days after vascular injury (blue staining indicates denuded endothelium) in IRKO and WTmice (magniﬁcation320). B: Time-
dependent endothelial regeneration is shown after vascular injury (n = 5 mice per group). *P< 0.05. Data are presented as mean and SEM. (A high-
quality digital representation of this ﬁgure is available in the online issue.)
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Compelling evidence now supports the concept that in
response to vascular injury, circulating progenitor cells are
mobilized from the BM—and possibly other tissues—into
the circulation, home to sites of EC damage, and contrib-
ute to vascular repair (42).
Our study provides evidence of reduced numbers of
APCs in the peripheral blood and impaired APC mobili-
zation in mice with mild whole-body insulin resistance but
normoglycemia. Emerging data support a role of insulin in
modulating progenitor cell function (43,44). Although
a reduced number of basal APCs was previously demon-
strated in a mouse model of diabetes (db/db mice) (14),
this is the ﬁrst evidence that insulin resistance per se is
associated with a reduction in peripheral APCs and im-
paired APC mobilization. We have shown that mice with
haploinsufﬁciency of the insulin receptor have reduced
basal and insulin-mediated endothelial NO production and
a progressive deterioration in NO bioavailability with age
(23,45).
It is interesting to note that although there was a re-
duction in the number of peripheral APCs in the IRKO
mice, there was no difference in the number of spleen- or
BM-derived APCs, potentially consistent with impaired
APC mobilization secondary to a reduction in NO bio-
availability. There is convincing evidence to suggest that
NO has a critical role to play in APC mobilization (46). In
keeping with this, we found reduced expression of eNOS
in BM in IRKO mice along with reduced eNOS activity in
the aorta. The ﬁnding of reduced APC numbers in this
mouse model of insulin resistance is in line with previously
published human data from our group showing diminished
APC numbers and impaired NO-dependent APC mobiliza-
tion in healthy insulin-resistant volunteers of South Asian
descent compared with normoglycemic insulin-sensitive
white European control subjects (21,32).
In addition to the circulating numbers of APCs, the
functional capacity of these cells is arguably of greater
pathophysiologic relevance. Although APCs enhance new
vessel formation, the process is likely to involve the par-
ticipation of mature resident ECs. After adhering to the
vessel wall, it has been suggested that a major function of
APCs could be the secretion of a portfolio of angiogenic
FIG. 6. Effects of cell transfusion on endothelial regeneration. A: En face microscopy demonstrates the presence of DiI-labeled MNCs at the injury
site 5 days after wire injury with no detectable cells in the uninjured vessel (magniﬁcation 3100). B: Corresponding nuclear staining of the en-
dothelium with DAPI revealing native endothelial cells and DiI-labeled transfused MNCs (magniﬁcation 3400). C: Effects of transfusion of spleen-
derived MNCs or BM-derived c-kit(CD117)+ cells from WT or IRKO mice are shown on endothelial regeneration 5 days after wire injury (n = 4 mice
per group). Data are presented as mean and SEM. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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factors that activate resident mature EC-mediated repair
(19). Here we show that despite similar adhesion capacity
of the cells, the angiogenic capacity of conditioned media
from IRKO-derived APCs is reduced. Because we restricted
our studies to APCs, we cannot rule out the possibility that
alterations in late outgrowth endothelial colony-forming
cells may also have contributed to dysfunctional endothelial
repair.
We have clearly demonstrated that endothelial re-
generation is signiﬁcantly impaired in IRKO mice com-
pared with WT littermates. Delayed endothelial repair has
previously been demonstrated in a mouse model of di-
abetes (14); however, this is the ﬁrst evidence directly
linking whole-body insulin resistance with impaired endo-
thelial regeneration. Although a cause-effect relationship
between the reduction in APC numbers and impaired en-
dothelial regeneration cannot be demonstrated at this stage,
previous work has shown that 55% of re-endothelialization
after wire injury is likely to be attributable to BM-derived
cells (47). Using an aortic ring angiogenesis assay, we
demonstrated no difference in the angiogenic capacity of
IRKO mice. Therefore, although impaired angiogenic re-
pair by mature ECs at sites of damage may partly account
for the delayed endothelial regeneration seen in IRKO
mice, the reduction in APCs and impaired APC mobilization
and function seen in this model provide a compelling case
for an impairment of APC-mediated repair in insulin-
resistant mice.
Other groups have used lethal irradiation, followed by
BM transplantation, to demonstrate the contribution of
BM-derived cells to endothelial repair (14). Because irra-
diation potentially leads to a number of deleterious effects
on recipient animals, including endothelial dysfunction
and apoptosis (48), there is concern regarding the physi-
ologic signiﬁcance of the ﬁndings observed in these stud-
ies. To avoid these problems and to further investigate the
potential therapeutic effect of APCs on endothelial repair,
we performed APC transfusion studies. Homing signals
for circulating progenitor cells mostly result from local
injury and guide them to the target tissue. In our study,
intravenously transfused cells were exclusively found at
the injury site. Transfusion of WT spleen-derived MNCs
into IRKO mice after vascular injury signiﬁcantly improved
endothelial repair. Because the spleen is a hematopoietic
organ in the mouse, it is not possible to determine which
exact cell type of the spleen-derived MNCs is responsible
for the observed beneﬁcial effect on endothelial repair.
It is tempting to speculate that the complex composition
of spleen-derived MNCs, including monocytes, macro-
phages, and other progenitor cells, all with differentia-
tion potential into APCs, leads to enhanced paracrine
interactions that ultimately lead to improved endothelial
repair.
To determine whether a pure population of insulin-
sensitive BM hematopoietic stem cells characterized by
the expression of the cell surface marker c-kit could aug-
ment repair, we infused WT c-kit+ BM cells into IRKO mice.
This led to normalization of endothelial regeneration, sug-
gesting an important role for this cell type. Transfusion of
IRKO c-kit+ cells resulted in an improvement but not nor-
malization of endothelial repair, underlining the importance
of the abnormal phenotype of progenitor cells from IRKO
mice.
Our studies in whole-body and endothelial-speciﬁc
insulin resistance provide potential insights into the
molecular basis for the APC dysfunction seen here. Our
observations that insulin resistance downregulates sig-
naling through the PI-3-kinase/akt/eNOS pathway (23,45)
and increases endothelial intracellular reactive oxygen
species (49) are pertinent. PI-3-kinase/akt/eNOS signaling
plays a key role in multiple facets of APC function, in-
cluding mobilization, homing, and migration (44,50). Im-
balance between intracellular reactive oxygen species and
endogenous oxidant defense mechanisms in endothelial
progenitors has recently emerged as a cause of impaired
ischemic neovascularization and wound healing in diabetes
(27,51–53). The consequences of insulin resistance on re-
active oxygen species and oxidant defenses in progenitor
cells warrant further investigation.
In summary, this dataset demonstrates that mild whole-
body insulin resistance reminiscent of the human sce-
nario reduces APC numbers, impairs APC mobilization
and function, and delays endothelial regeneration after
injury. Transfusion of WT but not IRKO APCs restores
regenerative capacity in IRKO mice. These data may have
important implications for the development of therapeutic
strategies for vascular disease associated with insulin re-
sistance.
FIG. 7. Aortic ring angiogenesis assay. A: Representative image demonstrates sprouting microvessels from an aortic ring cultured in Matrigel
(magniﬁcation 340). B: Quantiﬁcation of microvessels sprouting from aortic rings from IRKO and WT mice (n = 4 mice per group). Data are
presented as mean and SEM. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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